Patterns of Psychoactive Drug Administration to Nursing Home Residents with Distress Behavior in Dementia (RP116)
Kenneth S. Boockvar,Tianwen Huan,Kimberly Curyto,Sei Lee,Orna Intrator
DOI: https://doi.org/10.1016/j.jpainsymman.2024.02.460
IF: 5.576
2024-04-19
Journal of Pain and Symptom Management
Abstract:Outcomes 1. Understand patterns of psychoactive medication use in nursing home residents with distress behavior in dementia. 2. Apply knowledge of factors associated with psychoactive medication use to the care of nursing home residents with distress behavior in dementia. Key Message This study found that antipsychotic and benzodiazepine administration rose on the day of distress behavior incidents in nursing home residents with dementia, and that the antipsychotic increase persisted at least 30 days after the incident. Findings can inform initiatives to reduce psychoactive drug use for distress behaviors in dementia. Importance Distress behaviors in dementia (DBD) are common, decrease quality of life, and are burdensome to patients, families and caregivers. Despite risks, many nursing home (NH) residents are prescribed psychoactive medications for DBD. Objective(s) To examine frequency and predictors of psychoactive prescribing in a retrospective cohort of NH residents with DBD. Scientific Methods Utilized Department of Veterans Affairs (VA) data, including NH Minimum Data Set (MDS) assessments, were used to identify long-stay residents with dementia in 2019-20. Nurses in 61 facilities recorded DBD incidents by type, severity and frequency. The main outcome was daily psychoactive medication use by class (antipsychotics, benzodiazepines, antidepressants, antiepileptics) before, during, and after the DBD incident, according to bar-coded administration data. Using multivariate models, we examined associations between psychoactive medication use and DBD characteristics, cognitive and physical function, and health and demographics, controlling for prior psychoactive medication receipt. Results Of 2112 residents with dementia, 974 (46%) had DBD incidents recorded. Those with DBD were 74 years old on average, 97% male, 76% white, 17% Black, and had a mean activities of daily living (ADL) score of 14.1 (scale range 0-28); 46% had moderate-severe cognitive impairment by MDS Cognitive Function Score. Antipsychotic and benzodiazepine administration, but not antidepressant or antiepileptic administration, rose significantly on the day of the DBD incident, to 20% and 42% of residents, respectively. This increase persisted 30 days after the DBD incident for antipsychotics. Antipsychotic receipt was associated with worse cognitive function and greater frequency of DBD; and inversely associated with antidepressant receipt. Benzodiazepine receipt was associated with better cognitive function and inversely associated with gabapentin receipt. Conclusion(s) Psychoactive administration in NH residents increases on DBD incident days and antipsychotic administration persists at least 30 days after. Impact Reasons for inverse associations among psychoactive classes should be explored. Findings could inform initiatives to reduce psychoactive drug prescribing for DBD. Keywords Pain and symptom control/Psychosocial support
medicine, general & internal,clinical neurology,health care sciences & services